Enliven Therapeutics And Imara Announce Merger Agreement
Enliven Therapeutics, Inc. (Enliven), a clinical-stage precision oncology company focused on the discovery and development of next-generation small molecule kinase inhibitors, and Imara Inc. (NASDAQ:IMRA) (Imara) today